VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.648
-0.003 (-0.52%)
At close: Jun 26, 2026, 4:00 PM EDT
0.657
+0.008 (1.26%)
After-hours: Jun 26, 2026, 5:32 PM EDT
VYNE Therapeutics Employees
VYNE Therapeutics had 10 employees as of December 31, 2025. The number of employees decreased by 3 or -23.08% compared to the previous year.
Employees
10
Change (1Y)
-3
Growth (1Y)
-23.08%
Revenue / Employee
$45,400
Profits / Employee
-$2,145,700
Market Cap
21.62M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Celularity | 115 |
| Longeveron | 38 |
| Palatin Technologies | 29 |
| Lipocine | 14 |
| Tvardi Therapeutics | 12 |
| Cellectar Biosciences | 11 |
| Allarity Therapeutics | 8 |
VYNE News
- 6 weeks ago - VYNE Therapeutics Quarterly report: Q1 2026 - Filings
- 4 months ago - VYNE Therapeutics Annual report: Q4 2025 - Filings
- 6 months ago - VYNE Therapeutics Transcript: M&A Announcement - Transcripts
- 6 months ago - VYNE Therapeutics Press release: M&A Announcement - Filings
- 6 months ago - VYNE Therapeutics, Yarrow Bioscience enter merger agreement - TheFly
- 6 months ago - VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement - GlobeNewsWire
- 8 months ago - VYNE Therapeutics Proxy statement: Proxy Filing - Filings
- 8 months ago - VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year - TheFly